AMICUS THERAPEUTICS, INC. — Director's Dealing 2018

Apr 19, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2018-04-17

Reporting Person: Do Hung (Chief Science Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-04-17	Common Stock	S	50000	$15.00	Disposed	446771	Direct

Footnotes

F1: The sale of common stock was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2018.